[Livedo reticularis following administration of COVID-19 vaccine: a case report].

Livédo réticulaire post vaccin anti COVID-19: à propos d’un cas.

Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2024
Historique:
received: 02 10 2021
accepted: 12 12 2021
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: epublish

Résumé

The emergence of severe acute respiratory syndrome coronavirus 2 has made it crucial to develop safe vaccines. Three main types of vaccines are currently available. Although they have proven to be very secure, they have caused various adverse effects. We here report a rare case of livedo reticularis following the administration of COVID-19 vaccine in a 54-year-old woman. It occurred 24 hours after vaccination, accompanied by respiratory, digestive, and neurological disorders and deterioration in general condition. Examinations revealed skin lesions compatible with livedo reticularis, mild inflammatory syndrome and hypercholesterolemia. Imaging showed no abnormalities. Immunological tests were positive for lupus anticoagulant. The patient received symptomatic treatment, with improvement in neurological and joint symptoms and a slight regression of skin rashes. After three months, the lupus anticoagulant test remained positive, confirming post-vaccination antiphospholipid syndrome (APS). The association of livedo reticularis with COVID-19 vaccine should not be underestimated and its degree of severity remains to be determined. More data and cases need to be collected for a more in-depth and detailed analysis.

Identifiants

pubmed: 39372698
doi: 10.11604/pamj.2024.49.9.31779
pii: PAMJ-49-9
pmc: PMC11453108
doi:

Substances chimiques

COVID-19 Vaccines 0
Lupus Coagulation Inhibitor 0

Types de publication

Case Reports English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

9

Informations de copyright

Copyright: Meryem Ouhaddach et al.

Déclaration de conflit d'intérêts

Les auteurs ne déclarent aucun conflit d´intérêts.

Auteurs

Meryem Ouhaddach (M)

Service de Médecine Interne, Hôpital Arrazi CHU Mohamed VI, Marrakech, Maroc.

Mouna Zahlane (M)

Service de Médecine Interne, Hôpital Arrazi CHU Mohamed VI, Marrakech, Maroc.

Lamiaâ Essaadouni (L)

Service de Médecine Interne, Hôpital Arrazi CHU Mohamed VI, Marrakech, Maroc.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH